Canada markets closed

Oramed Pharmaceuticals Inc. (ORMP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.3500+0.0100 (+0.43%)
At close: 04:00PM EDT
2.3700 +0.02 (+0.85%)
After hours: 05:06PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 95.22M
Enterprise Value -15.20M
Trailing P/E 16.79
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)71.14
Price/Book (mrq)0.58
Enterprise Value/Revenue -11.35
Enterprise Value/EBITDA -2.08

Trading Information

Stock Price History

Beta (5Y Monthly) 1.82
52-Week Change 3-22.77%
S&P500 52-Week Change 322.38%
52 Week High 35.2500
52 Week Low 31.6700
50-Day Moving Average 32.7724
200-Day Moving Average 32.6288

Share Statistics

Avg Vol (3 month) 3150.26k
Avg Vol (10 day) 372.32k
Shares Outstanding 540.52M
Implied Shares Outstanding 640.52M
Float 836.7M
% Held by Insiders 111.30%
% Held by Institutions 112.88%
Shares Short (Apr 15, 2024) 4367.6k
Short Ratio (Apr 15, 2024) 43.11
Short % of Float (Apr 15, 2024) 41.00%
Short % of Shares Outstanding (Apr 15, 2024) 40.91%
Shares Short (prior month Mar 15, 2024) 4484.01k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Jan 23, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 412.31%
Operating Margin (ttm)-1,176.79%

Management Effectiveness

Return on Assets (ttm)-5.16%
Return on Equity (ttm)3.24%

Income Statement

Revenue (ttm)1.34M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)N/A
EBITDA -15.57M
Net Income Avi to Common (ttm)5.53M
Diluted EPS (ttm)0.1400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)162.05M
Total Cash Per Share (mrq)4
Total Debt (mrq)51.62M
Total Debt/Equity (mrq)31.69%
Current Ratio (mrq)3.06
Book Value Per Share (mrq)4.06

Cash Flow Statement

Operating Cash Flow (ttm)-10.29M
Levered Free Cash Flow (ttm)-9.69M